Description of Business (Details) - USD ($) $ in Thousands |
Feb. 20, 2020 |
Dec. 31, 2023 |
Dec. 31, 2022 |
---|---|---|---|
Business Acquisition [Line Items] | |||
Business combination, consideration transferred, equity interests issued (in shares) | 26,844,877 | ||
Business combination common stock under contingent value right (in shares) | 86,630,633 | ||
Contingent consideration liabilities | $ 2,700 | $ 111,600 | |
Progenics | |||
Business Acquisition [Line Items] | |||
Aggregate cash payments percentage | 40.00% | ||
Percentage of total consideration | 19.90% | ||
Business combination contingent value right of total consideration | $ 99,600 | ||
Progenics | Cash Payments, 2022 | |||
Business Acquisition [Line Items] | |||
Contingent consideration liabilities | 100,000 | ||
Progenics | Cash Payments, 2023 | |||
Business Acquisition [Line Items] | |||
Contingent consideration liabilities | $ 150,000 |